Study of markers of systemic inflammation (matrix metalloproteinase-9, vascular endothelial adhesion molecules of type 1) in patients with <i>ST</i> -segment elevation myocardial infarction at the hospital and outpatient stages

Aim. To study the level of MMP-9 and VCAM-1 in patients with AMI with ST-segment elevation at the hospital stage and one year after the index event, depending on the development of complications and changes in BMI and waist size (WS). Material and methods. The study included 126 people with STEMI...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Irina N. Zakovryashina, Vladislav A. Suroedov, Larisa A. Khaisheva, Sergey V. Shlyk, Azat S. Samakaev
Formato:	article
Lenguaje:	EN RU
Publicado:	Concilium Medicum 2021
Materias:	acute myocardial infarction markers of systemic inflammation matrix metalloproteinase type 9 vascular endothelial adhesion molecules of type 1 Diseases of the circulatory (Cardiovascular) system RC666-701 Diseases of the endocrine glands. Clinical endocrinology RC648-665
Acceso en línea:	https://doaj.org/article/19cd33b0f66747b597fef0d09d23989d
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:19cd33b0f66747b597fef0d09d23989d
record_format	dspace
spelling	oai:doaj.org-article:19cd33b0f66747b597fef0d09d23989d2021-12-01T22:07:01ZStudy of markers of systemic inflammation (matrix metalloproteinase-9, vascular endothelial adhesion molecules of type 1) in patients with <i>ST</i> -segment elevation myocardial infarction at the hospital and outpatient stages2221-71852658-570710.17816/22217185.2021.3.201046https://doaj.org/article/19cd33b0f66747b597fef0d09d23989d2021-10-01T00:00:00Zhttps://cardiosomatics.orscience.ru/2221-7185/article/viewFile/83268/63762https://doaj.org/toc/2221-7185https://doaj.org/toc/2658-5707Aim. To study the level of MMP-9 and VCAM-1 in patients with AMI with ST-segment elevation at the hospital stage and one year after the index event, depending on the development of complications and changes in BMI and waist size (WS). Material and methods. The study included 126 people with STEMI after PCI, as well as 27 people in the control group. The level of MMP-9 and VCAM-1 in peripheral blood was analyzed. In addition to the standard methods of examination and diagnosis, BMI and WS were measured to identify groups with visceral obesity. The assessment of the frequency and nature of complications after STEMI was performed. Results. The levels of biomarkers of vascular endothelial adhesion molecule type 1 and matrix metalloproteinase type 9 are increased in the acute period of STEMI, statistically significantly reduced, but remain elevated 12 months after the index event, with VCAM-1 by 3.5 times, and MMP by almost 2 times compared to the initial values. The level of MMP-9 is significantly higher in excess body mass index and waist size, and VCAM-1 has no association with visceral obesity. Vascular endothelial adhesion molecules of type 1 and matrix metalloproteinases of type 9 are increased in patients with a fatal outcome, as well as with an increase in the severity of OSN and CHF. The level of matrix metalloproteinase has a strong relationship with fatal outcome and repeated MI, and the vascular endothelial adhesion molecule type 1 has a stronger relationship with the severity of CHF. Conclusion. The article studied markers of systemic inflammation (matrix metalloproteinase type 9 and vascular endothelial adhesion molecules type 1) in patients with ST-segment elevation myocardial infarction, depending on the presence of obesity at the hospital and outpatient stages. Simultaneous determination of MMP-9 and VCAM-1 levels can be used to assess the intensity of the inflammatory process and the risk of adverse outcomes.Irina N. ZakovryashinaVladislav A. SuroedovLarisa A. KhaishevaSergey V. ShlykAzat S. SamakaevConcilium Medicumarticleacute myocardial infarctionmarkers of systemic inflammationmatrix metalloproteinase type 9vascular endothelial adhesion molecules of type 1Diseases of the circulatory (Cardiovascular) systemRC666-701Diseases of the endocrine glands. Clinical endocrinologyRC648-665ENRUКардиоСоматика, Vol 12, Iss 3, Pp 124-131 (2021)
institution	DOAJ
collection	DOAJ
language	EN RU
topic	acute myocardial infarction markers of systemic inflammation matrix metalloproteinase type 9 vascular endothelial adhesion molecules of type 1 Diseases of the circulatory (Cardiovascular) system RC666-701 Diseases of the endocrine glands. Clinical endocrinology RC648-665
spellingShingle	acute myocardial infarction markers of systemic inflammation matrix metalloproteinase type 9 vascular endothelial adhesion molecules of type 1 Diseases of the circulatory (Cardiovascular) system RC666-701 Diseases of the endocrine glands. Clinical endocrinology RC648-665 Irina N. Zakovryashina Vladislav A. Suroedov Larisa A. Khaisheva Sergey V. Shlyk Azat S. Samakaev Study of markers of systemic inflammation (matrix metalloproteinase-9, vascular endothelial adhesion molecules of type 1) in patients with <i>ST</i> -segment elevation myocardial infarction at the hospital and outpatient stages
description	Aim. To study the level of MMP-9 and VCAM-1 in patients with AMI with ST-segment elevation at the hospital stage and one year after the index event, depending on the development of complications and changes in BMI and waist size (WS). Material and methods. The study included 126 people with STEMI after PCI, as well as 27 people in the control group. The level of MMP-9 and VCAM-1 in peripheral blood was analyzed. In addition to the standard methods of examination and diagnosis, BMI and WS were measured to identify groups with visceral obesity. The assessment of the frequency and nature of complications after STEMI was performed. Results. The levels of biomarkers of vascular endothelial adhesion molecule type 1 and matrix metalloproteinase type 9 are increased in the acute period of STEMI, statistically significantly reduced, but remain elevated 12 months after the index event, with VCAM-1 by 3.5 times, and MMP by almost 2 times compared to the initial values. The level of MMP-9 is significantly higher in excess body mass index and waist size, and VCAM-1 has no association with visceral obesity. Vascular endothelial adhesion molecules of type 1 and matrix metalloproteinases of type 9 are increased in patients with a fatal outcome, as well as with an increase in the severity of OSN and CHF. The level of matrix metalloproteinase has a strong relationship with fatal outcome and repeated MI, and the vascular endothelial adhesion molecule type 1 has a stronger relationship with the severity of CHF. Conclusion. The article studied markers of systemic inflammation (matrix metalloproteinase type 9 and vascular endothelial adhesion molecules type 1) in patients with ST-segment elevation myocardial infarction, depending on the presence of obesity at the hospital and outpatient stages. Simultaneous determination of MMP-9 and VCAM-1 levels can be used to assess the intensity of the inflammatory process and the risk of adverse outcomes.
format	article
author	Irina N. Zakovryashina Vladislav A. Suroedov Larisa A. Khaisheva Sergey V. Shlyk Azat S. Samakaev
author_facet	Irina N. Zakovryashina Vladislav A. Suroedov Larisa A. Khaisheva Sergey V. Shlyk Azat S. Samakaev
author_sort	Irina N. Zakovryashina
title	Study of markers of systemic inflammation (matrix metalloproteinase-9, vascular endothelial adhesion molecules of type 1) in patients with <i>ST</i> -segment elevation myocardial infarction at the hospital and outpatient stages
title_short	Study of markers of systemic inflammation (matrix metalloproteinase-9, vascular endothelial adhesion molecules of type 1) in patients with <i>ST</i> -segment elevation myocardial infarction at the hospital and outpatient stages
title_full	Study of markers of systemic inflammation (matrix metalloproteinase-9, vascular endothelial adhesion molecules of type 1) in patients with <i>ST</i> -segment elevation myocardial infarction at the hospital and outpatient stages
title_fullStr	Study of markers of systemic inflammation (matrix metalloproteinase-9, vascular endothelial adhesion molecules of type 1) in patients with <i>ST</i> -segment elevation myocardial infarction at the hospital and outpatient stages
title_full_unstemmed	Study of markers of systemic inflammation (matrix metalloproteinase-9, vascular endothelial adhesion molecules of type 1) in patients with <i>ST</i> -segment elevation myocardial infarction at the hospital and outpatient stages
title_sort	study of markers of systemic inflammation (matrix metalloproteinase-9, vascular endothelial adhesion molecules of type 1) in patients with <i>st</i> -segment elevation myocardial infarction at the hospital and outpatient stages
publisher	Concilium Medicum
publishDate	2021
url	https://doaj.org/article/19cd33b0f66747b597fef0d09d23989d
work_keys_str_mv	AT irinanzakovryashina studyofmarkersofsystemicinflammationmatrixmetalloproteinase9vascularendothelialadhesionmoleculesoftype1inpatientswithistisegmentelevationmyocardialinfarctionatthehospitalandoutpatientstages AT vladislavasuroedov studyofmarkersofsystemicinflammationmatrixmetalloproteinase9vascularendothelialadhesionmoleculesoftype1inpatientswithistisegmentelevationmyocardialinfarctionatthehospitalandoutpatientstages AT larisaakhaisheva studyofmarkersofsystemicinflammationmatrixmetalloproteinase9vascularendothelialadhesionmoleculesoftype1inpatientswithistisegmentelevationmyocardialinfarctionatthehospitalandoutpatientstages AT sergeyvshlyk studyofmarkersofsystemicinflammationmatrixmetalloproteinase9vascularendothelialadhesionmoleculesoftype1inpatientswithistisegmentelevationmyocardialinfarctionatthehospitalandoutpatientstages AT azatssamakaev studyofmarkersofsystemicinflammationmatrixmetalloproteinase9vascularendothelialadhesionmoleculesoftype1inpatientswithistisegmentelevationmyocardialinfarctionatthehospitalandoutpatientstages
_version_	1718404148103217152

Study of markers of systemic inflammation (matrix metalloproteinase-9, vascular endothelial adhesion molecules of type 1) in patients with <i>ST</i> -segment elevation myocardial infarction at the hospital and outpatient stages

Ejemplares similares